This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brickman, T. J.
Right arrow Articles by Armstrong, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brickman, T. J.
Right arrow Articles by Armstrong, S. K.

 Previous Article  |  Next Article 

Journal of Bacteriology, December 2002, p. 7055-7057, Vol. 184, No. 24
0021-9193/02/$04.00+0     DOI: 10.1128/JB.184.24.7055-7057.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Alcaligin Siderophore Production by Bordetella bronchiseptica Strain RB50 Is Not Repressed by the BvgAS Virulence Control System

Timothy J. Brickman* and Sandra K. Armstrong

Department of Microbiology, University of Minnesota Medical School, Minneapolis, Minnesota 55455-0312

Received 9 September 2002/ Accepted 17 September 2002


arrow
ABSTRACT
 
A previous study found that alcaligin siderophore production by Bordetella bronchiseptica strain RB50 is Bvg repressed. In contrast, we report that alcaligin production by RB50 does not require Bvg phenotypic phase modulation and that isogenic Bvg(Con) and Bvg- phase-locked mutants both produce alcaligin in response to iron starvation.


arrow
TEXT
 
Bordetella species are gram-negative respiratory pathogens of humans and other animals (26) that can undergo virulence-associated phenotypic alterations in response to environmental signals. This phenotypic modulation is mediated by the BvgAS sensory transduction system (1, 33, 34). Most virulence-associated traits are expressed in the Bvg+ phenotypic phase, and in laboratory cultures the switch from the Bvg+ to the Bvg- phase can be induced by supplementation of culture medium with nicotinic acid (NA) (28, 29) or MgSO4 (20) or by culturing at a low temperature (20).

Siderophores are low-molecular-mass, high-affinity iron chelators of microbial origin that are produced coordinately with their cognate receptors and transporters in response to iron starvation (21). Bordetella pertussis and Bordetella bronchiseptica produce the potent siderophore alcaligin (10, 24). Transcription of alcaligin biosynthesis and transport genes is negatively regulated by Fur and iron (3, 8, 9, 18, 19) and positively regulated by AlcR (4, 27) by using the alcaligin siderophore as the inducer (11).

A previous study reported that the B. bronchiseptica rabbit isolate strain RB50 produced alcaligin siderophore only in the Bvg- phenotypic phase (17). The additional observations that the isogenic Bvg- phase-locked mutant RB54 (13) did not require phenotypic modulation for alcaligin production and that the Bvg(Con) phase-locked mutant RB53 (13) did not produce detectable alcaligin under any growth condition provided compelling evidence for Bvg repression of alcaligin production in B. bronchiseptica RB50. A subsequent phenotypic survey in that study, involving 114 other B. bronchiseptica strains, led to the conclusion that Bvg repression of alcaligin production was significantly associated with phylogenetic lineage and mammalian host source. Although this is the only published report of Bvg repression of alcaligin production in B. bronchiseptica, it has frequently been cited in scientific publications, including several review articles (5, 7, 12, 16, 23, 25, 31), as providing an important example of a Bvg-repressed trait, with implications for pathogenicity and host specificity.

In contrast with key findings of that previous study, we report that (i) siderophore production by wild-type B. bronchiseptica strain RB50 does not require modulation to the Bvg- phase and is independent of Bvg phenotypic phase, and (ii) isogenic Bvg(Con) and Bvg- phase-locked mutant derivatives of RB50 both produce siderophores at wild-type levels in response to iron starvation. Furthermore, biological and biochemical analysis confirmed that RB50 (Bvg+ phase), RB53, and RB54 all produce siderophores with properties identical to those of alcaligin.

Siderophore production by the wild-type B. bronchiseptica strain RB50 does not require phenotypic modulation to Bvg- phase. B. bronchiseptica strains (Table 1) were cultured at 37°C on Bordet-Gengou (6) agar plates containing 20% defibrinated sheep blood. After 24 h of growth on Bordet-Gengou agar plates, bacteria were transferred to iron-replete Stainer-Scholte broth (SS) (29, 32) and cultured at 37°C with shaking for 24 h. These iron-replete seed cultures were harvested by centrifugation, washed with iron-depleted SS, and seeded to iron-replete and iron-depleted SS cultures as described previously (2), at an initial cell density corresponding to an optical density at 600 nm of 0.02. After 24 h, cleared culture supernatants were quantitatively assayed for alcaligin by the chrome azurol S (CAS) method (30), using highly purified alcaligin (10) as the standard. The wild-type strain RB50 was cultured for siderophore production assays under nonmodulating (Bvg+) conditions. RB50 produced very high levels (circa 150 µM, or about 60 µg/ml) of alcaligin in the Bvg+ phase in response to iron starvation (Table 2).


View this table:
[in this window]
[in a new window]
  		TABLE 1. B. bronchiseptica strains and bacteriophage


View this table:
[in this window]
[in a new window]
  		TABLE 2. Alcaligin production by B. bronchiseptica strains cultured in iron-depleted SS under various conditions of phenotypic modulation

Modulation to the Bvg- phenotypic phase does not result in elevated siderophore production by wild-type strain RB50 compared with Bvg+-phase organisms. In phenotypic modulation experiments, RB50 was cultured for siderophore production (i) in the presence of NA at concentrations ranging from 0.1 to 16.0 mM, (ii) in the presence of 50 mM MgSO4, or (iii) at 20°C, in parallel with nonmodulated cultures. All modulating (Bvg-) culture conditions (except for iron-depleted cultures with >=8.0 mM NA, which did not grow) resulted in the production of high levels of siderophore under iron starvation conditions and showed no significant increase over levels produced by nonmodulated, Bvg+-phase RB50 organisms (Table 2). The Bvg phenotypic phase of modulated and nonmodulated alcaligin-producing bacteria recovered from iron-depleted cultures was confirmed by a bacteriophage adsorption assay as described previously (22) using the Bvg+-phase-specific bacteriophage BP3c (data not shown).

Bvg(Con) and Bvg- phase-locked mutants both produce siderophores. Isogenic Bvg phase-locked mutant strains RB53 and RB54 both produced alcaligin at levels comparable to the parental wild-type strain RB50 (Table 2) in response to iron starvation, providing genetic evidence for Bvg-independent alcaligin production in this strain lineage. These data are consistent with our RB50 phenotypic modulation experiments, which showed equivalent alcaligin production by RB50 in both Bvg+ and Bvg- phenotypic phases.

RB50, RB53, and RB54 culture supernatants stimulate growth of alcaligin indicator strains. In iron-restricted growth stimulation bioassays (10), supernatants from iron-depleted cultures (nonmodulating SS) of RB50, RB53, and RB54 stimulated the growth of alcaligin-deficient mutant BRM1 to equivalent levels (Table 3), but no supernatants stimulated the growth of the ferric alcaligin receptor (fauA) mutant BRM17, indicating that the growth-stimulating substance present in the supernatants was alcaligin. Control iron sources were human hemoglobin (Sigma) and purified alcaligin (10).


View this table:
[in this window]
[in a new window]
  		TABLE 3. Growth stimulation of iron source indicator strains

Siderophores of RB50, RB53, and RB54 are purified by the alcaligin extraction method, are ferric iron reactive, and comigrate with purified alcaligin in thin-layer chromatography. Siderophores were extracted from 3-ml volumes of supernatants from iron-depleted cultures (nonmodulating SS) of RB50, RB53, and RB54 by using a scaled-down benzyl alcohol-ether extraction procedure (10). Purified siderophores were analyzed by silica gel thin-layer chromatography against a purified alcaligin standard as described previously (10) by using an n-butanol-acetic acid-H2O (4:1:5, upper phase) solvent system (Fig. 1). Red ferric iron-reactive species were visualized by spraying the plates with 1% FeCl3 in 0.1 mM HCl. All three strains produced a single ferric iron-reactive species that comigrated with authentic alcaligin.



View larger version (53K):
[in this window]
[in a new window]
  		FIG. 1. Analytical silica gel thin-layer chromatography of siderophores purified from iron-depleted SS culture supernatants of RB50 (Bvg+ phase), RB53, and RB54. Dots at the lower edge of the chromatogram indicate the origin for each sample. The arrowhead indicates the position of a red spot (Rf = 0.53) corresponding to ferric alcaligin complexes (10). Alcaligin control sample, 5 µg.

Summary. Conflicting results regarding a relationship between Bvg phenotypic phase and alcaligin production in B. bronchiseptica strain RB50 were obtained in this study compared with the previous report of Giardina et al. (17), using the same RB50-related bacterial strains and culture conditions. Although the previous study used the Csaky method (14) in primary screening for hydroxamate siderophore production, strains that were Csaky negative for alcaligin production were further tested with the CAS siderophore assay, so the discrepancy between reports cannot be simply explained by differences in assay methods. Most importantly, we find that (i) RB50 produces high levels of alcaligin under nonmodulating (Bvg+ phase) conditions, and (ii) the Bvg(Con) phase-locked mutant RB53 also produces high levels of alcaligin. These are positive results that argue strongly that alcaligin production is not Bvg repressed in these strains.


arrow
ACKNOWLEDGMENTS
 
We thank Peggy A. Cotter, Jeff F. Miller, and Minghsun Liu for providing B. bronchiseptica strains RB50, RB53, and RB54 and for bacteriophage BP3c. We are especially grateful to Peggy Cotter for encouragement and discussions.

This work was supported by Public Health Service grant AI-31088 from the National Institute of Allergy and Infectious Diseases.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Microbiology, University of Minnesota, MMC 196 FUMC, 420 Delaware St. SE, Minneapolis, MN 55455-0312. Phone: (612) 624-5177. Fax: (612) 626-0623. E-mail: brickman{at}lenti.med.umn.edu. Back


arrow
REFERENCES
 
    1
  1. Arico, B., J. F. Miller, C. Roy, S. Stibitz, D. Monack, S. Falkow, R. Gross, and R. Rappuoli. 1989. Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc. Natl. Acad. Sci. USA 86:6671-6675.[Abstract/Free Full Text]
    2. 2
  2. Armstrong, S. K., and M. O. Clements. 1993. Isolation and characterization of Bordetella bronchiseptica mutants deficient in siderophore activity. J. Bacteriol. 175:1144-1152.[Abstract/Free Full Text]
    3. 3
  3. Beall, B. W., and G. N. Sanden. 1995. Cloning and initial characterization of the Bordetella pertussis fur gene. Curr. Microbiol. 30:223-226.[CrossRef][Medline]
    4. 4
  4. Beaumont, F. C., H. Y. Kang, T. J. Brickman, and S. K. Armstrong. 1998. Identification and characterization of alcR, a gene encoding an AraC-like regulator of alcaligin siderophore biosynthesis and transport in Bordetella pertussis and Bordetella bronchiseptica. J. Bacteriol. 180:862-870.[Abstract/Free Full Text]
    5. 5
  5. Bock, A., and R. Gross. 2001. The BvgAS two-component system of Bordetella spp.: a versatile modulator of virulence gene expression. Int. J. Med. Microbiol. 291:119-130.[CrossRef][Medline]
    6. 6
  6. Bordet, J., and O. Gengou. 1906. Le microbe de la coqueluche. Ann. Inst. Pasteur (Paris) 20:731-741.
    7. 7
  7. Braun, V., K. Hantke, and W. Koster. 1998. Bacterial iron transport: mechanisms, genetics, and regulation. Met. Ions Biol. Syst. 35:67-145.[Medline]
    8. 8
  8. Brickman, T. J., and S. K. Armstrong. 1995. Bordetella pertussis fur gene restores iron repressibility of siderophore and protein expression to deregulated Bordetella bronchiseptica mutants. J. Bacteriol. 177:268-270.[Abstract/Free Full Text]
    9. 9
  9. Brickman, T. J., and S. K. Armstrong. 1999. Essential role of the iron-regulated outer membrane receptor FauA in alcaligin siderophore-mediated iron uptake in Bordetella species. J. Bacteriol. 181:5958-5966.[Abstract/Free Full Text]
    10. 10
  10. Brickman, T. J., J. G. Hansel, M. J. Miller, and S. K. Armstrong. 1996. Purification, spectroscopic analysis and biological activity of the macrocyclic dihydroxamate siderophore alcaligin produced by Bordetella pertussis and Bordetella bronchiseptica. Biometals 9:191-203.[Medline]
    11. 11
  11. Brickman, T. J., H. Y. Kang, and S. K. Armstrong. 2001. Transcriptional activation of Bordetella alcaligin siderophore genes requires the AlcR regulator with alcaligin as inducer. J. Bacteriol. 183:483-489.[Abstract/Free Full Text]
    12. 12
  12. Coote, J. G. 2001. Environmental sensing mechanisms in Bordetella. Adv. Microb. Physiol. 44:141-181.[Medline]
    13. 13
  13. Cotter, P. A., and J. F. Miller. 1994. BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect. Immun. 62:3381-3390.[Abstract/Free Full Text]
    14. 14
  14. Csaky, T. Z. 1948. On the estimation of bound hydroxylamine in biological materials. Acta Chem. Scand. 2:450-454.[CrossRef]
    15. 15
  15. Farrington, D. O., and W. P. Switzer. 1979. Parenteral vaccination of young swine against Bordetella bronchiseptica. Am. J. Vet. Res. 40:1347-1351.[Medline]
    16. 16
  16. Gerlach, G., F. von Wintzingerode, B. Middendorf, and R. Gross. 2001. Evolutionary trends in the genus Bordetella. Microbes Infect. 3:61-72.[CrossRef][Medline]
    17. 17
  17. Giardina, P. C., L. A. Foster, J. M. Musser, B. J. Akerley, J. F. Miller, and D. W. Dyer. 1995. bvg repression of alcaligin synthesis in Bordetella bronchiseptica is associated with phylogenetic lineage. J. Bacteriol. 177:6058-6063.[Abstract/Free Full Text]
    18. 18
  18. Kang, H. Y., and S. K. Armstrong. 1998. Transcriptional analysis of the Bordetella alcaligin siderophore biosynthesis operon. J. Bacteriol. 180:855-861.[Abstract/Free Full Text]
    19. 19
  19. Kang, H. Y., T. J. Brickman, F. C. Beaumont, and S. K. Armstrong. 1996. Identification and characterization of iron-regulated Bordetella pertussis alcaligin siderophore biosynthesis genes. J. Bacteriol. 178:4877-4884.[Abstract/Free Full Text]
    20. 20
  20. Lacey, B. W. 1960. Antigenic modulation of Bordetella pertussis. J. Hyg. Camb. 58:57-93.[Medline]
    21. 21
  21. Lankford, C. E. 1973. Bacterial assimilation of iron. Crit. Rev. Microbiol. 2:273-331.
    22. 22
  22. Liu, M., R. Deora, S. R. Doulatov, M. Gingery, F. A. Eiserling, A. Preston, D. J. Maskell, R. W. Simons, P. A. Cotter, J. Parkhill, and J. F. Miller. 2002. Reverse transcriptase-mediated tropism switching in Bordetella bacteriophage. Science 295:2091-2094.[Abstract/Free Full Text]
    23. 23
  23. Mattoo, S., A. K. Foreman-Wykert, P. A. Cotter, and J. F. Miller. 2001. Mechanisms of Bordetella pathogenesis. Front. Biosci. 6:E168-E186.[Medline]
    24. 24
  24. Moore, C. H., L. A. Foster, D. G. Gerbig, Jr., D. W. Dyer, and B. W. Gibson. 1995. Identification of alcaligin as the siderophore produced by Bordetella pertussis and B. bronchiseptica. J. Bacteriol. 177:1116-1118.[Abstract/Free Full Text]
    25. 25
  25. Ottemann, K. M., and J. F. Miller. 1997. Roles for motility in bacterial-host interactions. Mol. Microbiol. 24:1109-1117.[CrossRef][Medline]
    26. 26
  26. Parton, R. 1999. Review of the biology of Bordetella pertussis. Biologicals 27:71-76.[CrossRef][Medline]
    27. 27
  27. Pradel, E., N. Guiso, and C. Locht. 1998. Identification of AlcR, an AraC-type regulator of alcaligin siderophore synthesis in Bordetella bronchiseptica and Bordetella pertussis. J. Bacteriol. 180:871-880.[Abstract/Free Full Text]
    28. 28
  28. Pusztai, S., and I. Joo. 1967. Influence of nicotinic acid on the antigenic structure of Bordetella pertussis. Ann. Immunol. Hung. 10:63-67.
    29. 29
  29. Schneider, D. R., and C. D. Parker. 1982. Effect of pyridines on phenotypic properties of Bordetella pertussis. Infect. Immun. 38:548-553.[Abstract/Free Full Text]
    30. 30
  30. Schwyn, B., and J. B. Neilands. 1987. Universal chemical assay for the detection and determination of siderophores. Anal. Biochem. 160:47-56.[CrossRef][Medline]
    31. 31
  31. Smith, A. M., C. A. Guzman, and M. J. Walker. 2001. The virulence factors of Bordetella pertussis: a matter of control. FEMS Microbiol. Rev. 25:309-333.[CrossRef][Medline]
    32. 32
  32. Stainer, D. W., and M. J. Scholte. 1970. A simple chemically defined medium for the production of phase I Bordetella pertussis. J. Gen. Microbiol. 63:211-220.[Abstract/Free Full Text]
    33. 33
  33. Uhl, M. A., and J. F. Miller. 1995. Bordetella pertussis BvgAS virulence control system, p. 333-349. In J. A. Hoch and T. J. Silhavy (ed.), Two-component signal transduction. ASM Press. Washington, D.C.
    34. 34
  34. Weiss, A. A., E. L. Hewlett, G. A. Myers, and S. Falkow. 1983. Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect. Immun. 42:33-41.[Abstract/Free Full Text]

Journal of Bacteriology, December 2002, p. 7055-7057, Vol. 184, No. 24
0021-9193/02/$04.00+0     DOI: 10.1128/JB.184.24.7055-7057.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Brickman, T. J., Armstrong, S. K. (2005). Bordetella AlcS Transporter Functions in Alcaligin Siderophore Export and Is Central to Inducer Sensing in Positive Regulation of Alcaligin System Gene Expression. J. Bacteriol. 187: 3650-3661 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brickman, T. J.
Right arrow Articles by Armstrong, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brickman, T. J.
Right arrow Articles by Armstrong, S. K.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»